Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis [Phase 3]
This update reports the Phase 3 results for the oral agent BG00012 in relapsing-remitting multiple sclerosis, focusing on efficacy and safet…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Safety and Efficacy of Natalizumab (BG00002, Tysabri®) in Russian Participants With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 4]
Phase 4 clinical trial update showing safety and efficacy data for Natalizumab (Tysabri) in Russian participants with relapsing-remitting mu…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis
Clinical trial update describing the effect of fingolimod on cardiac autonomic regulation in patients with relapsing-remitting multiple scle…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Natalizumab De-escalation With Interferon Beta-1b [Phase 4]
Phase 4 trial evaluating de-escalation of natalizumab with interferon beta-1b in relapse-remitting multiple sclerosis; the study completed a…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis [Phase 2]
This is a Phase 2 trial update of intravenous immune globulin (IGIV) for relapsing-remitting multiple sclerosis, with results posted in 2014…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod [Phase 3]
A Phase 3 trial assessing disease control and safety in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingol…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx [Phase 3]
Phase 3 MSCombiRx trial evaluating combination therapy with interferon beta-1a and glatiramer acetate in relapsing-remitting multiple sclero…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 3]
Phase 3 trial evaluating a new daily subcutaneous formulation of glatiramer acetate for relapsing-remitting multiple sclerosis was terminate…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone
Observational study assessing outcomes for relapsing-remitting MS patients who start or restart baseline interferon beta-1a after prior esca…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis
A Canadian clinical trial evaluating the utility of treatment optimization recommendations in relapsing-remitting multiple sclerosis has com…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Phase IIa Study of NT-KO-003 for Multiple Sclerosis [Phase 2]
A Phase IIa study evaluating NT-KO-003 for relapsing-remitting multiple sclerosis has completed, according to trial records.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)
A postmarketing surveillance study evaluated whether a variable titration regimen at the start of Rebif treatment improves patient complianc…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients [Phase 4]
Phase 4 clinical trial from Tehran University of Medical Sciences evaluated vitamin A supplementation on immune parameters in relapsing-remi…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Autologous T Cell Vaccine (TCV) for Multiple Sclerosis [Phase 2]
Phase 2 trial of an autologous T cell vaccine (TCV) for relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis [Phase 2]
This entry documents the completion of a Phase 2 trial evaluating Rituximab in adults with relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF)
This completed observational study evaluated quality of life and the influence of cognitive status on QoL in relapsing-remitting multiple sc…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis [Phase 4]
Phase 4 trial evaluating de-escalation from natalizumab to interferon-beta-1b in relapsing-remitting multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate [Phase 4]
Phase 4 trial assessing the effect of steroids in Relapsing Remitting Multiple Sclerosis patients treated with glatiramer acetate; the study…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 2]
Phase 2 study evaluating the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis; the trial has complete…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) [Phase 3]
A Phase 3 safety and efficacy study of oral cladribine in relapsing-remitting multiple sclerosis has completed; results were posted in 2013.…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: CLARITY Extension Study [Phase 3]
Phase 3 extension study update for relapsing-remitting multiple sclerosis; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif [Phase 4]
Phase 4 safety study in relapsing-remitting multiple sclerosis patients treated with Betaferon or Rebif; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients [Phase 3]
A Phase 3 trial comparing two glatiramer acetate formulations in relapsing-remitting multiple sclerosis completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients
A completed clinical trial evaluating the prevalence of spasticity in relapsing-remitting multiple sclerosis and its impact on quality of li…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™.
An observational study evaluating adherence, effectiveness and convenience of Rebif treatment in relapsing-remitting multiple sclerosis pati…